denosumab April 12, 2017 denosumab Trade Name Xgeva Orphan Indication Hypercalcemia in malignancy USA Market Approval USA USA Designation Date 2013-09-11 00:00:00 Sponsor Amgen, Inc.;One Amgen Center Drive, MS 17-2-C;Thousand Oaks, California, 91320
